Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro

REFERENCES

• Potier P. The synthesis of the Navelbine prototype of a new series of vinblastine derivatives. Semin Oncol 1989; 16: 2–4.
   PubMedGoogle Scholar
• Lobert S, Vulevic B, Correia JJ. Interaction of vinca alkaloids with tubulin: a comparison of vinblastin, vincristine, and vinorelbine. Biochemistry 1996; 35: 6806–14.
   Google Scholar
• Besenval M, Delgado M, Demarez JP, Krikorian A. Safety and tolerance of Navelbine in phase I-II clinical studies. Semin Oncol 1989; 16(Suppl 4): 37–40.
   PubMedGoogle Scholar
• Canobbio L, Boccardo F, Pastorino G, et al. Phase-II study of navelbine in advanced breast cancer. Semin Oncol 1989; 16(Suppl 4): 33–6.
   PubMed Web of Science ®Google Scholar
• George MJ, Heron JF, Kerbrat P, et al. Navelbine in advanced ovarian epithelial cancer: a study of the French Oncology Centers. Semin Oncol 1989; 16(Suppl 4): 30–2.
   PubMed Web of Science ®Google Scholar
• DePierre A, Lemarie F, Dabouis G, Gamier G, Jacoulet P, Dalphin JC. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer. Am J Clin Oncol 1991; 14: 115–9.
   PubMed Web of Science ®Google Scholar
• Edelstein MP, Wolfe III LA, Duch DS. Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer. Semin Oncol 1996; 23(Suppl 5): 41–7.
   PubMedGoogle Scholar
• Gridelli C, Guida C, Barletta E, et al. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study. Lung Cancer 2000; 29: 131–7.
   PubMed Web of Science ®Google Scholar
• Yokes EE, Weichselbaum RR. Concomitant chemoradiother-apy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990; 8: 911–34.
   PubMedGoogle Scholar
• Fu KK, Phillips TL, Silverberg U, et al. Combined radio-therapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410–8.
   PubMed Web of Science ®Google Scholar
• Haffty BG, Son YH, Papac R, et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. J Clin Oncol 1997; 15: 268–76.
   PubMed Web of Science ®Google Scholar
• Yokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR. Favorable long-term survival following induc-tion chemotherapy with cisplatin, fluorouracil and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 1992; 84: 877–82.
   PubMedGoogle Scholar
• Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798–804.
   PubMed Web of Science ®Google Scholar
• Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea and hyperfractio-nated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001; 19: 1961–9.
   PubMedGoogle Scholar
• Erjala K, Pulkkinen J, Kulmala J, Alanen K, Grenman R. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in vitro. Anticancer Res 2002; 22: 3135–42.
   Google Scholar
• Lansford CD, Grenman R, Bier H, et al. Chapter 28: Head and neck cancers. In: Masters JRW, Palsson B, eds. Human cell culture, vol. II. UK: Kluwer Academic Publishers; 1999. p. 185–255.
   Google Scholar
• Grenman R, Burk D, Virolainen E, et al. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 1989; 44: 131–6.
   PubMed Web of Science ®Google Scholar
• Kulmala J, Rantanen V, Pekkola-Heino K, Tuominen J, Gren-man R. Dosimetry of irradiation models: the 96-well clono-genic assay for testing radiosensitivity of cell lines. Acta Oncol 1995; 34: 105–9.
   Google Scholar
• Pekkola-Heino K, Kulmala J, Grenman R. Carboplatin-radia-tion interaction in squamous carcinoma cell lines. Arch Otolaryngol Head Neck Surg 1992; 118: 1312–5.
   Google Scholar
• Engblom P, Pulkkinen JO, Rantanen V, et al. Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis. Eur J Cancer 1999; 35: 2: 284–8.
   PubMedGoogle Scholar
• Orecchia R, Jereczek-Fossa BA, Catalano G, et al. Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer. Oncology 2002; 63: 115–23.
   PubMedGoogle Scholar